References
- Brandon, E. F., Raap, C. D., Meijerman, I., Beijnen, J. H. and Schellens, J. H. : An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 189, 233 (2003). https://doi.org/10.1016/S0041-008X(03)00128-5
- McGinnity, D. F., Zhang, G., Kenny, J. R., Hamilton, G. A., Otmani, S., Stams, K. R., Haney, S., Brassil, P., Stresser, D. M. and Riley, R. J. : Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: Human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells. Drug. Metab. Dispos. 37, 1259 (2009). https://doi.org/10.1124/dmd.109.026526
- Fahmi, O. A. and Ripp, S. L. : Evaluation of models for prediction drug-drug interactions due to induction. Expert. Opin. Drug. Metab. Toxicol. 6, 1399 (2010). https://doi.org/10.1517/17425255.2010.516251
- Drug Interaction Studies - Study design, data analysis, implications for dosing, and labeling recommendations, guidance for industry, FDA, Silver Spring, 2-75 (2012).
- Yuan, R., Madani, S., Wei, X. X., Reynolds, K. and Huang, S. M. : Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug. Metab. Dispos. 30, 1311 (2002). https://doi.org/10.1124/dmd.30.12.1311
- Balimane, P. V., Han, Y. H. and Chong, S. : Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical. AAPS J. 10, 391 (2008). https://doi.org/10.1208/s12248-008-9037-4
- Hewitt, N. J., Lecluyse, E. L. and Ferguson, S. S. : Induction of hepatic cytochrome P450 enzymes: Methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica. 37, 1196 (2007). https://doi.org/10.1080/00498250701534893
- Rodriguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V. and Gomez-Lechon, M. J. : Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanism that determine lower expression in cultured cells. Xenobiotica. 32, 505 (2002). https://doi.org/10.1080/00498250210128675
- Zhang, L., Zhang Y., Zhao, P. and Huang, S. M. : Prediction drug-drug interactions: An FDA perspective. AAPS J. 11, 2 (2009).
- Guideline on the investigation of drug interactions, European Medicines Agency, 4-38 (2010).
- Antherieu, S., Chesne, C., Li, R., Camus, S., Lahoz, A., Picazo, L., Turpeinen, M., Tolonen, A., Uusitalo, J., Guguen-Guillouzo, C. and Guillouzo, A. : Stable expression, activity and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug. Metab. Dispos. 38, 516 (2010). https://doi.org/10.1124/dmd.109.030197
- Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F. and Guguen-Guillouzo, C. : The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168, 66 (2007). https://doi.org/10.1016/j.cbi.2006.12.003
- Lubberstedt, M., Muller-Vieira, U., Mayer, M., Biemel, K. M., Knospel, F., Knobeloch, D., Nussler, A. K., Gerlach, J. C. and Zeilinger, K. : HepaRG human hepatic cell line utililty as a surrogate for primary human Hepatocytes in drug metabolism assessment in vitro. J. Pharmacol. Toxicol. Methods 63, 59 (2011). https://doi.org/10.1016/j.vascn.2010.04.013
- Bowen, W. P., Carey, J. E., Miah, A., McMurray, H. F., Munday, P. W., James, R. S., Coleman, R. A. and Brown, A. M. : Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptasepolymerase chain reaction. Drug. Metab. Dispos. 28, 781 (2000).
- Kanebratt, K. P. and Andersson, T. B. : Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug. Metab. Dispos. 36, 1444 (2008). https://doi.org/10.1124/dmd.107.020016
- Turpeinen, M., Tolonen, A., Chesne, C., Guillouzo, A., Uusitalo, J. and Pelkonen, O. : Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicol. In Vitro 23, 748 (2009). https://doi.org/10.1016/j.tiv.2009.03.008
- Tolonen, A., Petsalo, A., Turpeinen, M., Uusitalo, J. and Pelkonen, O. : In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies. J. Mass Spectrom. 42, 960 (2007). https://doi.org/10.1002/jms.1239
- Li, X., Chen, X., Li, Q., Wang, L. and Zhong, D. : Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 852, 128 (2007). https://doi.org/10.1016/j.jchromb.2007.01.006
- Wrishko, R. E., Dingemanse, J., Yu, A., Darstein, C., Phillips, D. L. and Mitchell, M. I. : Pharmacokinetic interaction between tadalafil and Bosentan in healthy male subjects. J. Clin. Pharmacol. 48, 610 (2008). https://doi.org/10.1177/0091270008315315
- Kenworthy, K. E., Bloomer, J. C., Clarke, S. E. and Houston, J. B. : CYP3A4 drug interactions: correlation of 10 in vitro probes substrates. Br. J. Clin. Pharmacol. 48, 716 (1999).
- Fahmi, O. A., Kish, M., Boldt, S. and Obach, R. S. : Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug. Metab. Dispos. 38, 1605 (2010). https://doi.org/10.1124/dmd.110.033126